Klotho (KL) (N-Term) Peptide
Aperçu rapide pour Klotho (KL) (N-Term) Peptide (ABIN978987)
Antigène
Origine
Source
Application
-
-
Protein Region
- N-Term
-
Séquence
- GAAPSDSPIV VAPSGAPSPP LSSTGDVASD SYNNVYRDTE GLRELGVTHY
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-Kl Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Klotho (KL)
-
Sujet
-
Kl may have weak glycosidase activity towards glucuronylated steroids. However, it lacks essential active site Glu residues at positions 241 and 874, suggesting it may be inactive as a glycosidase in vivo. It may be involved in the regulation of calcium and phosphorus homeostasis by inhibiting the synthesis of active vitamin D. Essential factor for the specific interaction between FGF23 and FGFR1.
Alias Symbols: alpha-kl
Protein Size: 1014 -
Poids moléculaire
- 116 kDa
-
ID gène
- 16591
-
NCBI Accession
- NM_013823, NP_038851
-
UniProt
- O35082
Antigène
-